BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,998.74
      -0.38%
      US Tech 100
      20,240.00
      -0.65%
      Dow Jones
      44,722.06
      -0.31%
      Brent Oil
      72.735
      0.08%
      Bitcoin
      96,234.48
      0.60%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inovio Pharmaceuticals Inc New (INO)

      7. Inovio Pharmaceuticals Inc New (INO) Financials

      Inovio Pharmaceuticals Inc New

      Inovio Pharmaceuticals Inc New (INO)

      Inseego Corp
      4.19
      0.18
      (4.49%)
      Closed November 29 4:00PM
      Delayed by 15 minutes
      4.0211
      -0.1689
      (-4.03%)
      After Hours: 7:58PM
      Delayed by 15 minutes

      Inovio Pharmaceuticals Inc New Financial Summary

      The current INO market cap is 104.95M. The company's latest EPS is USD -5.1769 and P/E is -0.81.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 226k388k103k0101k
      Operating Income -36.88M-35.34M-27.61M-31.61M-33.53M
      Net Income -35.53M-33.93M-25M-30.47M-32.24M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 4.11M7.41M1.78M10.26M832k
      Operating Income -114.2M-87.53M-301.77M-269.47M-143.17M
      Net Income -119.36M-166.41M-303.66M-279.82M-135.12M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 233.04M193.1M170.95M129.11M133.8M
      Total Liabilities 63.67M54.94M53.6M34.67M37.06M
      Total Equity 169.37M138.16M117.35M94.44M96.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 143.95M539.77M495.94M348.53M170.95M
      Total Liabilities 138.55M78.63M96.27M126.17M53.6M
      Total Equity 5.41M461.14M399.67M222.36M117.35M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -68.98M-98.09M-124.37M-28.76M-56.97M
      Investing 72.91M67.41M87.36M45.38M55.35M
      Financing 2.46M3.16M5M-11.36M21.67M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -97.85M-177.98M-215.71M-216.22M-124.37M
      Investing -9.05M-58.8M-175.34M109.59M87.36M
      Financing 105.4M465.28M211.5M81.84M5M

      Stats and Ratios

      Market Cap 104.95M
      Price to Earnings Ratio -0.81
      Price to Sales Ratio 131.66
      Price to Cash Ratio 7.66
      Price to Book Ratio 0.93
      Dividend Yield -

      Share Statistics

      Shares Outstanding 26.1M
      Average Volume (1 week) 456.66k
      Average Volume (1 Month) 396.28k
      52 Week Change -18.11%
      52 Week High 14.748
      52 Week Low 3.8699
      Spread (Intraday) 0.22 (5.19%)

      Company Info

      Company Name Inovio Pharmaceuticals Inc New
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.inovio.com
      Industry surgical,med instr,apparatus (3841)